WHC is still in active development. Read this to understand our approach.
depiction of QSLJIVKCVHQPLV-UHFFFAOYSA-N.svg
isomerdesign

Oxandrolone

Check on isomerdesign

pubchem

Oxandrolone

Check on pubchem

drugmap

Oxandrolone

Check on drugmap

Data

InChI: InChI=1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3

Synonyms: Oxandrolone (JAN/USP/INN),OXANDROLONE [MI],2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5-alpha,17-beta)-,Oxandrolone, >=98% (HPLC),2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5.alpha.,17.beta.)-,OXANDROLONE [USP MONOGRAPH],AC-14975, Dodecahydro-3-hydroxy-6-(hydroxy-methyl)-3,3a,6-trimethyl-1H-benz(e)indene-7-acetic acid delta-lactone,D00462, SC-11585,OXANDROLONE [USAN],8075 CB,HY-B0707,CHEMBL1200436,Provitar,Dodecahydro-3-hydroxy-6-(hydroxy-methyl)-3,3a,6-trimethyl-1H-benz(e)indene-7-acetic acid delta-lactone,Oxandrolone,Oxandrolonum [INN-Latin],8075 C. B., (1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one,17α-Methyl-2-oxa-4,5α-dihydrotestosterone,OXANDROLONE [ORANGE BOOK], SC 11585,2-Oxa-5alpha-androstan-3-one, 17beta-hydroxy-17-methyl-,SR-01000872645,7H6TM3CT4L,53-39-4,SC 11585,17beta-Hydroxy-17-methyl-2-oxa-5alpha-androstan-3-one,Ossandrolone [DCIT],DB00621, Oxandrolonum [INN-Latin],Oxandrolona [INN-Spanish],CHEBI:7820,17alpha-Methyl-17beta-hydroxy-2-oxa-5alpha-androstan-3-one, Anavar (TN),Protivar,17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one,OXANDROLONE,Oxandrolone ciii,SC-11585, Ossandrolone [DCIT],Oxandrolone [USAN:USP:INN:BAN:JAN],UNII-7H6TM3CT4L,C07346,AKOS025401400, Lonavar,17α-Methyl-2-oxa-5α-androstan-17β-ol-3-one,OXANDROLONE [VANDF],NSC 67068,(4aS,4bS,6aS,7S,9aS,9bR,11aS)-7-hydroxy-4a,6a,7-trimethyltetradecahydroindeno[4,5-h]isochromen-2(1H)-one,GTPL7092, Provitar,Lonavar, Ossandrolone,OXANDROLONE CIII [USP-RS], Oxandrolone [USAN:INN:BAN:JAN], Oxandrolona [INN-Spanish],HSDB 3373, Vasorome,AB01559948-01, Oxandrin, Anavar, Oxandrolone,Oxandrolone (JAN/USP/INN), 2-Oxa-5alpha-androstan-3-one, 17beta-hydroxy-17-methyl-(8CI), Oxandrin,(1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,14,15-trimethyl-4-oxatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one, 17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one,Oxandrin,ZINC3813047,(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one,Oxandrin;Anavar,2-Oxa-5-alpha-androstan-3-one, 17-beta-hydroxy-17-methyl-, 17beta-Hydroxy-17-methyl-2-oxa-5alpha-androstan-3-one,OXANDROLONE [HSDB],OXANDROLONE [MART.],198O944,8075 C.B.,SCHEMBL148881,DTXSID8023399,CCG-220110, Oxandrolona, Protivar,NSC-67068,Anavar,Ossandrolone,SR-01000872645-1,Oxandrin (TN),OXANDROLONE [WHO-DD],W-105740, Oxandrin (TN),HMS3712E22,Oxandrolona, 17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one (9CI), 2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5-alpha,17-beta)-(9CI),EINECS 200-172-9,OXANDROLONE [INN], 17beta-Hydroxy-17alpha-methyl-2-oxa-5alpha-androstan-3-one, Oxandrolonum, (4aS,4bS,6aS,7S,9aS,9bR,11aS)-7-hydroxy-4a,6a,7-trimethyltetradecahydroindeno[4,5-h]isochromen-2(1H)-one,Q420859,17beta-Hydroxy-17alpha-methyl-2-oxa-5alpha-androstan-3-one,Oxandrolonum,OXANDROLONE [JAN],2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5alpha,17beta)-,Vasorome


Estimated data

Solubility: -4.503 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 64.5% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.